🇬🇧 Kymriah in United Kingdom

Kymriah (TISAGENLECLEUCEL) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Local brand name: Kymriah
  • Status: approved

Kymriah in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Kingdom

Frequently asked questions

Is Kymriah approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Kymriah in United Kingdom?

Novartis Pharmaceuticals Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.